Darbepoetin Alfa — Drug Intelligence | 4 EU Trials

Filter these 4 trials by condition, phase, country and more.

4 Registered trials

3 Recruiting

0 Completed trials

3 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 1 Phase IV: 1

Indications tested

4 total

Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis Not authorised

2023-503634-50-00 Phase III 5 countries Genexine Inc.
Darbepoetin in patients candidates for liver transplant: randomized clinical trial Recruiting

2025-521701-41-00 Phase IV 1 country Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis Recruiting

2023-503634-50-01 Phase III 6 countries Genexine Inc.
Darbepoetin for neonatal stroke Recruiting

2024-513042-12-01 Phase II 1 country Universitair Medisch Centrum Utrecht

Showing 1–4 of 4 trials